Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Armando Cesolini"'
Autor:
Felicia Grasso, Maurizio Federico, Claudia J. Dembek, Stefano M. Santini, Heinke Conrad, Giuseppe Laconi, Colomba Giorgi, Claudia Muratori, Armando Cesolini, Stefania Mochi, Paola Di Bonito, Emanuele Fanales-Belasio, Antonio Cosma, Arianna Mei, Helga Bernhard, Simona Donati, Caterina Lapenta, Linda Petrone
Publikováno v:
Virology. 395(1):45-55
Here we report a novel strategy for the induction of CD8(+) T cell adaptive immune response against viral and tumor antigens. This approach relies on high levels of incorporation in HIV-1 VLPs of a mutant of HIV-1 Nef (Nef(mut)) which can act as anch
Autor:
Roberto Belli, Simonetta Di Fabio, Maria Teresa Maggiorella, Armando Cesolini, Franco Corrias, Zuleika Michelini, Paola Verani, Fausto Titti, Silvia Baroncelli, Livia Cioè, Martin Luther Koanga-Mogtomo, Iole Macchia, Leonardo Sernicola
Publikováno v:
Virology. 256(2):291-302
The infection of cynomolgus monkeys with an attenuated simian immunodeficiency virus (SIV) (C8) carrying a deletion in the nef gene results in a persistent infection associated with an extremely low viral burden in peripheral blood mononuclear cells.
Autor:
Pasqualina Leone, Colomba Giorgi, Maria Vincenza Chiantore, Andrea Giovannelli, Armando Cesolini, Andrea Cara, Donatella R.M. Negri, Felicia Grasso, Alessandra Rossi, Stefania Mochi
Persistent infection with high risk genotypes of human papillomavirus (HPV) is the cause of cervical cancer, one of most common cancer among woman worldwide, and represents an important risk factor associated with other anogenital and oropharyngeal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4968a100917755892e800e7c1c1959f4
http://hdl.handle.net/11573/1405962
http://hdl.handle.net/11573/1405962
Autor:
Linda Petrone, Colomba Giorgi, Armando Cesolini, Fabiana Superti, Stefano Caimi, Maria Grazia Ammendolia, Paola Di Bonito
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 69 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 69 (2011)
Background The HPV16 E7 protein is both a tumour-specific and a tumour-rejection antigen, the ideal target for developing therapeutic vaccines for the treatment of HPV16-associated cancer and its precursor lesions. E7, which plays a key role in virus
Autor:
Martin Luther Koanga-Mogtomo, Franco Corrias, Leonardo Sernicola, Armando Cesolini, Fausto Titti, Donatella R.M. Negri, Carlo D. Baroni, Maria Teresa Maggiorella, IT Istituto Superiore di Sanit, Paola Verani
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3421e11a48c8acfac795d1361cbdedc4
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000081376400017&KeyUID=WOS:000081376400017
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000081376400017&KeyUID=WOS:000081376400017